ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Zika Virus Therapeutic Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-39A13245
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Zika Virus Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Zika Virus Therapeutic Market Research Report 2025

Code: QYRE-Auto-39A13245
Report
January 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson and Johnson
Aurobindo Pharma
Granules India
Perrigo
Sun Pharmaceutical
Bharat Biotech
Emergent Biosolutions
Takeda Pharmaceutical
GeoVax Labs
IMV
Inovio Pharmaceuticals
Moderna, Inc
Merck
Valneva

The global market for Zika Virus Therapeutic was valued at US$ 825 million in the year 2024 and is projected to reach a revised size of US$ 1241 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Zika Virus Therapeutic Market

Zika Virus Therapeutic Market

Zika virus infection is triggered by an Aedes mosquito-borne virus that bites during the day. In general, the symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise, or headache.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Zika Virus Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zika Virus Therapeutic.
The Zika Virus Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Zika Virus Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zika Virus Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Zika Virus Therapeutic Market Report

Report Metric Details
Report Name Zika Virus Therapeutic Market
Accounted market size in year US$ 825 million
Forecasted market size in 2031 US$ 1241 million
CAGR 6.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson and Johnson, Aurobindo Pharma, Granules India, Perrigo, Sun Pharmaceutical, Bharat Biotech, Emergent BioSolutions, Takeda Pharmaceutical, GeoVax Labs, IMV, Inovio Pharmaceuticals, Moderna, Merck, Valneva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Zika Virus Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Zika Virus Therapeutic Market growing?

Ans: The Zika Virus Therapeutic Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Zika Virus Therapeutic Market size in 2031?

Ans: The Zika Virus Therapeutic Market size in 2031 will be US$ 1241 million.

Who are the main players in the Zika Virus Therapeutic Market report?

Ans: The main players in the Zika Virus Therapeutic Market are Johnson and Johnson, Aurobindo Pharma, Granules India, Perrigo, Sun Pharmaceutical, Bharat Biotech, Emergent BioSolutions, Takeda Pharmaceutical, GeoVax Labs, IMV, Inovio Pharmaceuticals, Moderna, Merck, Valneva

What are the Application segmentation covered in the Zika Virus Therapeutic Market report?

Ans: The Applications covered in the Zika Virus Therapeutic Market report are Institutional Pharmacies, Retail Pharmacies, Others

What are the Type segmentation covered in the Zika Virus Therapeutic Market report?

Ans: The Types covered in the Zika Virus Therapeutic Market report are Acetaminophen, Other NSAIDs

Recommended Reports

Antiviral Therapeutics

Infection Treatments

Vaccine Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Zika Virus Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Acetaminophen
1.2.3 Other NSAIDs
1.3 Market by Application
1.3.1 Global Zika Virus Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Institutional Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Zika Virus Therapeutic Market Perspective (2020-2031)
2.2 Global Zika Virus Therapeutic Growth Trends by Region
2.2.1 Global Zika Virus Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Zika Virus Therapeutic Historic Market Size by Region (2020-2025)
2.2.3 Zika Virus Therapeutic Forecasted Market Size by Region (2026-2031)
2.3 Zika Virus Therapeutic Market Dynamics
2.3.1 Zika Virus Therapeutic Industry Trends
2.3.2 Zika Virus Therapeutic Market Drivers
2.3.3 Zika Virus Therapeutic Market Challenges
2.3.4 Zika Virus Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Zika Virus Therapeutic Players by Revenue
3.1.1 Global Top Zika Virus Therapeutic Players by Revenue (2020-2025)
3.1.2 Global Zika Virus Therapeutic Revenue Market Share by Players (2020-2025)
3.2 Global Zika Virus Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Zika Virus Therapeutic Revenue
3.4 Global Zika Virus Therapeutic Market Concentration Ratio
3.4.1 Global Zika Virus Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Zika Virus Therapeutic Revenue in 2024
3.5 Global Key Players of Zika Virus Therapeutic Head office and Area Served
3.6 Global Key Players of Zika Virus Therapeutic, Product and Application
3.7 Global Key Players of Zika Virus Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Zika Virus Therapeutic Breakdown Data by Type
4.1 Global Zika Virus Therapeutic Historic Market Size by Type (2020-2025)
4.2 Global Zika Virus Therapeutic Forecasted Market Size by Type (2026-2031)
5 Zika Virus Therapeutic Breakdown Data by Application
5.1 Global Zika Virus Therapeutic Historic Market Size by Application (2020-2025)
5.2 Global Zika Virus Therapeutic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Zika Virus Therapeutic Market Size (2020-2031)
6.2 North America Zika Virus Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Zika Virus Therapeutic Market Size by Country (2020-2025)
6.4 North America Zika Virus Therapeutic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Zika Virus Therapeutic Market Size (2020-2031)
7.2 Europe Zika Virus Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Zika Virus Therapeutic Market Size by Country (2020-2025)
7.4 Europe Zika Virus Therapeutic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Zika Virus Therapeutic Market Size (2020-2031)
8.2 Asia-Pacific Zika Virus Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Zika Virus Therapeutic Market Size by Region (2020-2025)
8.4 Asia-Pacific Zika Virus Therapeutic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Zika Virus Therapeutic Market Size (2020-2031)
9.2 Latin America Zika Virus Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Zika Virus Therapeutic Market Size by Country (2020-2025)
9.4 Latin America Zika Virus Therapeutic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Zika Virus Therapeutic Market Size (2020-2031)
10.2 Middle East & Africa Zika Virus Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Zika Virus Therapeutic Market Size by Country (2020-2025)
10.4 Middle East & Africa Zika Virus Therapeutic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Zika Virus Therapeutic Introduction
11.1.4 Johnson and Johnson Revenue in Zika Virus Therapeutic Business (2020-2025)
11.1.5 Johnson and Johnson Recent Development
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Company Details
11.2.2 Aurobindo Pharma Business Overview
11.2.3 Aurobindo Pharma Zika Virus Therapeutic Introduction
11.2.4 Aurobindo Pharma Revenue in Zika Virus Therapeutic Business (2020-2025)
11.2.5 Aurobindo Pharma Recent Development
11.3 Granules India
11.3.1 Granules India Company Details
11.3.2 Granules India Business Overview
11.3.3 Granules India Zika Virus Therapeutic Introduction
11.3.4 Granules India Revenue in Zika Virus Therapeutic Business (2020-2025)
11.3.5 Granules India Recent Development
11.4 Perrigo
11.4.1 Perrigo Company Details
11.4.2 Perrigo Business Overview
11.4.3 Perrigo Zika Virus Therapeutic Introduction
11.4.4 Perrigo Revenue in Zika Virus Therapeutic Business (2020-2025)
11.4.5 Perrigo Recent Development
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Details
11.5.2 Sun Pharmaceutical Business Overview
11.5.3 Sun Pharmaceutical Zika Virus Therapeutic Introduction
11.5.4 Sun Pharmaceutical Revenue in Zika Virus Therapeutic Business (2020-2025)
11.5.5 Sun Pharmaceutical Recent Development
11.6 Bharat Biotech
11.6.1 Bharat Biotech Company Details
11.6.2 Bharat Biotech Business Overview
11.6.3 Bharat Biotech Zika Virus Therapeutic Introduction
11.6.4 Bharat Biotech Revenue in Zika Virus Therapeutic Business (2020-2025)
11.6.5 Bharat Biotech Recent Development
11.7 Emergent BioSolutions
11.7.1 Emergent BioSolutions Company Details
11.7.2 Emergent BioSolutions Business Overview
11.7.3 Emergent BioSolutions Zika Virus Therapeutic Introduction
11.7.4 Emergent BioSolutions Revenue in Zika Virus Therapeutic Business (2020-2025)
11.7.5 Emergent BioSolutions Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Zika Virus Therapeutic Introduction
11.8.4 Takeda Pharmaceutical Revenue in Zika Virus Therapeutic Business (2020-2025)
11.8.5 Takeda Pharmaceutical Recent Development
11.9 GeoVax Labs
11.9.1 GeoVax Labs Company Details
11.9.2 GeoVax Labs Business Overview
11.9.3 GeoVax Labs Zika Virus Therapeutic Introduction
11.9.4 GeoVax Labs Revenue in Zika Virus Therapeutic Business (2020-2025)
11.9.5 GeoVax Labs Recent Development
11.10 IMV
11.10.1 IMV Company Details
11.10.2 IMV Business Overview
11.10.3 IMV Zika Virus Therapeutic Introduction
11.10.4 IMV Revenue in Zika Virus Therapeutic Business (2020-2025)
11.10.5 IMV Recent Development
11.11 Inovio Pharmaceuticals
11.11.1 Inovio Pharmaceuticals Company Details
11.11.2 Inovio Pharmaceuticals Business Overview
11.11.3 Inovio Pharmaceuticals Zika Virus Therapeutic Introduction
11.11.4 Inovio Pharmaceuticals Revenue in Zika Virus Therapeutic Business (2020-2025)
11.11.5 Inovio Pharmaceuticals Recent Development
11.12 Moderna
11.12.1 Moderna Company Details
11.12.2 Moderna Business Overview
11.12.3 Moderna Zika Virus Therapeutic Introduction
11.12.4 Moderna Revenue in Zika Virus Therapeutic Business (2020-2025)
11.12.5 Moderna Recent Development
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Zika Virus Therapeutic Introduction
11.13.4 Merck Revenue in Zika Virus Therapeutic Business (2020-2025)
11.13.5 Merck Recent Development
11.14 Valneva
11.14.1 Valneva Company Details
11.14.2 Valneva Business Overview
11.14.3 Valneva Zika Virus Therapeutic Introduction
11.14.4 Valneva Revenue in Zika Virus Therapeutic Business (2020-2025)
11.14.5 Valneva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Johnson and Johnson
Aurobindo Pharma
Granules India
Perrigo
Sun Pharmaceutical
Bharat Biotech
Emergent Biosolutions
Takeda Pharmaceutical
GeoVax Labs
IMV
Inovio Pharmaceuticals
Moderna, Inc
Merck
Valneva
List of Tables
 Table 1. Global Zika Virus Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Acetaminophen
 Table 3. Key Players of Other NSAIDs
 Table 4. Global Zika Virus Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Zika Virus Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Zika Virus Therapeutic Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Zika Virus Therapeutic Market Share by Region (2020-2025)
 Table 8. Global Zika Virus Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Zika Virus Therapeutic Market Share by Region (2026-2031)
 Table 10. Zika Virus Therapeutic Market Trends
 Table 11. Zika Virus Therapeutic Market Drivers
 Table 12. Zika Virus Therapeutic Market Challenges
 Table 13. Zika Virus Therapeutic Market Restraints
 Table 14. Global Zika Virus Therapeutic Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Zika Virus Therapeutic Market Share by Players (2020-2025)
 Table 16. Global Top Zika Virus Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zika Virus Therapeutic as of 2024)
 Table 17. Ranking of Global Top Zika Virus Therapeutic Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Zika Virus Therapeutic Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Zika Virus Therapeutic, Headquarters and Area Served
 Table 20. Global Key Players of Zika Virus Therapeutic, Product and Application
 Table 21. Global Key Players of Zika Virus Therapeutic, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Zika Virus Therapeutic Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Zika Virus Therapeutic Revenue Market Share by Type (2020-2025)
 Table 25. Global Zika Virus Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Zika Virus Therapeutic Revenue Market Share by Type (2026-2031)
 Table 27. Global Zika Virus Therapeutic Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Zika Virus Therapeutic Revenue Market Share by Application (2020-2025)
 Table 29. Global Zika Virus Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Zika Virus Therapeutic Revenue Market Share by Application (2026-2031)
 Table 31. North America Zika Virus Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Zika Virus Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Zika Virus Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Zika Virus Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Zika Virus Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Zika Virus Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Zika Virus Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Zika Virus Therapeutic Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Zika Virus Therapeutic Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Zika Virus Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Zika Virus Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Zika Virus Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Zika Virus Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Zika Virus Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Zika Virus Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Johnson and Johnson Company Details
 Table 47. Johnson and Johnson Business Overview
 Table 48. Johnson and Johnson Zika Virus Therapeutic Product
 Table 49. Johnson and Johnson Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 50. Johnson and Johnson Recent Development
 Table 51. Aurobindo Pharma Company Details
 Table 52. Aurobindo Pharma Business Overview
 Table 53. Aurobindo Pharma Zika Virus Therapeutic Product
 Table 54. Aurobindo Pharma Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 55. Aurobindo Pharma Recent Development
 Table 56. Granules India Company Details
 Table 57. Granules India Business Overview
 Table 58. Granules India Zika Virus Therapeutic Product
 Table 59. Granules India Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 60. Granules India Recent Development
 Table 61. Perrigo Company Details
 Table 62. Perrigo Business Overview
 Table 63. Perrigo Zika Virus Therapeutic Product
 Table 64. Perrigo Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 65. Perrigo Recent Development
 Table 66. Sun Pharmaceutical Company Details
 Table 67. Sun Pharmaceutical Business Overview
 Table 68. Sun Pharmaceutical Zika Virus Therapeutic Product
 Table 69. Sun Pharmaceutical Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 70. Sun Pharmaceutical Recent Development
 Table 71. Bharat Biotech Company Details
 Table 72. Bharat Biotech Business Overview
 Table 73. Bharat Biotech Zika Virus Therapeutic Product
 Table 74. Bharat Biotech Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 75. Bharat Biotech Recent Development
 Table 76. Emergent BioSolutions Company Details
 Table 77. Emergent BioSolutions Business Overview
 Table 78. Emergent BioSolutions Zika Virus Therapeutic Product
 Table 79. Emergent BioSolutions Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 80. Emergent BioSolutions Recent Development
 Table 81. Takeda Pharmaceutical Company Details
 Table 82. Takeda Pharmaceutical Business Overview
 Table 83. Takeda Pharmaceutical Zika Virus Therapeutic Product
 Table 84. Takeda Pharmaceutical Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 85. Takeda Pharmaceutical Recent Development
 Table 86. GeoVax Labs Company Details
 Table 87. GeoVax Labs Business Overview
 Table 88. GeoVax Labs Zika Virus Therapeutic Product
 Table 89. GeoVax Labs Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 90. GeoVax Labs Recent Development
 Table 91. IMV Company Details
 Table 92. IMV Business Overview
 Table 93. IMV Zika Virus Therapeutic Product
 Table 94. IMV Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 95. IMV Recent Development
 Table 96. Inovio Pharmaceuticals Company Details
 Table 97. Inovio Pharmaceuticals Business Overview
 Table 98. Inovio Pharmaceuticals Zika Virus Therapeutic Product
 Table 99. Inovio Pharmaceuticals Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 100. Inovio Pharmaceuticals Recent Development
 Table 101. Moderna Company Details
 Table 102. Moderna Business Overview
 Table 103. Moderna Zika Virus Therapeutic Product
 Table 104. Moderna Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 105. Moderna Recent Development
 Table 106. Merck Company Details
 Table 107. Merck Business Overview
 Table 108. Merck Zika Virus Therapeutic Product
 Table 109. Merck Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 110. Merck Recent Development
 Table 111. Valneva Company Details
 Table 112. Valneva Business Overview
 Table 113. Valneva Zika Virus Therapeutic Product
 Table 114. Valneva Revenue in Zika Virus Therapeutic Business (2020-2025) & (US$ Million)
 Table 115. Valneva Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Zika Virus Therapeutic Picture
 Figure 2. Global Zika Virus Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Zika Virus Therapeutic Market Share by Type: 2024 VS 2031
 Figure 4. Acetaminophen Features
 Figure 5. Other NSAIDs Features
 Figure 6. Global Zika Virus Therapeutic Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Zika Virus Therapeutic Market Share by Application: 2024 VS 2031
 Figure 8. Institutional Pharmacies Case Studies
 Figure 9. Retail Pharmacies Case Studies
 Figure 10. Others Case Studies
 Figure 11. Zika Virus Therapeutic Report Years Considered
 Figure 12. Global Zika Virus Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Zika Virus Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Zika Virus Therapeutic Market Share by Region: 2024 VS 2031
 Figure 15. Global Zika Virus Therapeutic Market Share by Players in 2024
 Figure 16. Global Top Zika Virus Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zika Virus Therapeutic as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Zika Virus Therapeutic Revenue in 2024
 Figure 18. North America Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Zika Virus Therapeutic Market Share by Country (2020-2031)
 Figure 20. United States Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Zika Virus Therapeutic Market Share by Country (2020-2031)
 Figure 24. Germany Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Zika Virus Therapeutic Market Share by Region (2020-2031)
 Figure 32. China Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Zika Virus Therapeutic Market Share by Country (2020-2031)
 Figure 40. Mexico Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Zika Virus Therapeutic Market Share by Country (2020-2031)
 Figure 44. Turkey Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Zika Virus Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Johnson and Johnson Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 48. Aurobindo Pharma Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 49. Granules India Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 50. Perrigo Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 51. Sun Pharmaceutical Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 52. Bharat Biotech Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 53. Emergent BioSolutions Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 55. GeoVax Labs Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 56. IMV Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 57. Inovio Pharmaceuticals Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 58. Moderna Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 59. Merck Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 60. Valneva Revenue Growth Rate in Zika Virus Therapeutic Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Zika Virus Detection Market Research Report 2024
Global Zika Virus Market Insights Forecast to 2030
Global Zika Virus Test Kit Market Research Report 2024
Global Zika Virus Infection Treatment Market Research Report 2025
Global Chikungunya Rapid Testing Market Research Report 2025
Global Yellow Fever Virus Testing Market Research Report 2024
Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mosquito Borne Infections Testing Market Research Report 2024
Global Mosquito Control Market Research Report 2024
Global Yellow Fever Virus Test Kit Market Research Report 2024
Global Zika Virus Testing Market Insights Forecast to 2030
Global Zika Virus Infection Drug Market Research Report 2024
Chikungunya Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Yellow Fever Treatment Market Research Report 2024
Global Herpes Zoster Ophthalmicus Drug Market Insights Forecast to 2030
Global Ebola Treatment Market Research Report 2024
Global Tropical and Vector borne Infectious Diseases Market Research Report 2024
Global Mosquito Repellants Market Research Report 2025
Global Arthropod Born Viral Infections Market Research Report 2025
Global Herpes Zoster Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions